{"id":"tp-59649","type":"article-newspaper","title":"Jaguar Health Targets Mid-2027 MVID Filing After More Than $10 Million in Debt Reduction","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/59649","datePublished":"2026-11-17T17:03:19.000Z","dateModified":"2026-11-17T17:03:19.000Z","language":"en","abstract":"Participants in the pivotal pediatric MVID trial have entered extension dosing. Jaguar also plans to seek breakthrough therapy designation in 2027.","section":"Business","references":[{"title":"quarterly results","url":"https://www.tokenpost.com/news/business/58474"}]}